Laurus Labs [LAURUSLABS] vs Cipla [CIPLA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Laurus Labs wins in 2 metrics, Cipla wins in 18 metrics, with 0 ties. Cipla appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricLaurus LabsCiplaBetter
P/E Ratio (TTM)88.4522.33Cipla
Price-to-Book Ratio10.043.86Cipla
Debt-to-Equity Ratio60.051.40Cipla
PEG Ratio0.072.19Laurus Labs
EV/EBITDA41.0515.78Cipla
Profit Margin (TTM)8.58%19.62%Cipla
Operating Margin (TTM)16.90%22.31%Cipla
EBITDA Margin (TTM)16.90%22.31%Cipla
Return on Equity7.79%16.85%Cipla
Return on Assets (TTM)3.84%14.10%Cipla
Free Cash Flow (TTM)$-393.50M$34.57BCipla
Dividend Yield0.18%1.72%Cipla
1-Year Return79.18%4.16%Laurus Labs
Price-to-Sales Ratio (TTM)7.584.46Cipla
Enterprise Value$510.85B$1,118.64BCipla
EV/Revenue Ratio8.624.07Cipla
Gross Profit Margin (TTM)59.39%68.25%Cipla
Revenue per Share (TTM)$110$340Cipla
Earnings per Share (Diluted)$9.41$66.73Cipla
Beta (Stock Volatility)0.330.10Cipla
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Laurus Labs vs Cipla Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Laurus Labs1.04%-10.71%-4.18%22.33%35.38%35.19%
Cipla-0.36%-4.85%-5.09%-0.75%1.57%1.35%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Laurus Labs79.18%62.24%196.88%774.91%774.91%774.91%
Cipla4.16%34.48%93.97%136.67%363.06%886.71%

News Based Sentiment: Laurus Labs vs Cipla

Laurus Labs

News based Sentiment: MIXED

September was a pivotal month for Laurus Labs, showcasing impressive financial growth alongside emerging challenges like US tariffs and mixed analyst opinions. The company's strategic investments and strong CDMO performance are positive indicators, but investors need to carefully weigh these against potential headwinds and valuation concerns.

View Laurus Labs News Sentiment Analysis

Cipla

News based Sentiment: MIXED

Cipla delivered strong financial results in September, but these were tempered by a declining stock price, a leadership change, and emerging concerns about US tariffs. The mixed signals create both opportunities and risks for investors, making this a significant month for the company.

View Cipla News Sentiment Analysis

Performance & Financial Health Analysis: Laurus Labs vs Cipla

MetricLAURUSLABSCIPLA
Market Information
Market Cap i₹455.69B₹1.23T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,061,8571,177,460
90 Day Avg. Volume i1,531,3621,203,818
Last Close₹840.95₹1,494.00
52 Week Range₹427.05 - ₹944.00₹1,335.00 - ₹1,607.80
% from 52W High-10.92%-7.08%
All-Time High₹944.00 (Sep 19, 2025)₹1,607.80 (Aug 25, 2025)
% from All-Time High-10.92%-7.08%
Growth Metrics
Quarterly Revenue Growth0.31%0.03%
Quarterly Earnings Growth12.03%0.10%
Financial Health
Profit Margin (TTM) i0.09%0.20%
Operating Margin (TTM) i0.17%0.22%
Return on Equity (TTM) i0.08%0.17%
Debt to Equity (MRQ) i60.051.40
Cash & Liquidity
Book Value per Share (MRQ)₹82.94₹386.24
Cash per Share (MRQ)₹2.67₹131.44
Operating Cash Flow (TTM) i₹4.13B₹55.16B
Levered Free Cash Flow (TTM) i₹3.58B₹52.73B
Dividends
Last 12-Month Dividend Yield i0.18%1.72%
Last 12-Month Dividend i₹1.20₹26.00

Valuation & Enterprise Metrics Analysis: Laurus Labs vs Cipla

MetricLAURUSLABSCIPLA
Price Ratios
P/E Ratio (TTM) i88.4522.33
Forward P/E i35.6123.45
PEG Ratio i0.072.19
Price to Sales (TTM) i7.584.46
Price to Book (MRQ) i10.043.86
Market Capitalization
Market Capitalization i₹455.69B₹1.23T
Enterprise Value i₹510.85B₹1.12T
Enterprise Value Metrics
Enterprise to Revenue i8.624.07
Enterprise to EBITDA i41.0515.78
Risk & Other Metrics
Beta i0.330.10
Book Value per Share (MRQ) i₹82.94₹386.24

Financial Statements Comparison: Laurus Labs vs Cipla

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)LAURUSLABSCIPLA
Revenue/Sales i₹15.70B₹68.37B
Cost of Goods Sold i₹6.37B₹21.71B
Gross Profit i₹9.32B₹46.66B
Research & Development iN/AN/A
Operating Income (EBIT) i₹2.65B₹15.25B
EBITDA i₹3.93B₹20.37B
Pre-Tax Income i₹2.24B₹17.70B
Income Tax i₹631.40M₹4.78B
Net Income (Profit) i₹1.62B₹12.92B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)LAURUSLABSCIPLA
Cash & Equivalents i₹995.40M₹5.89B
Total Current Assets i₹43.32B₹232.89B
Total Current Liabilities i₹35.40B₹54.84B
Long-Term Debt i₹7.08B₹2.52B
Total Shareholders Equity i₹46.03B₹312.89B
Retained Earnings i₹36.26B₹256.44B
Property, Plant & Equipment i₹1.89B₹52.62B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)LAURUSLABSCIPLA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLAURUSLABSCIPLA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i2,061,8571,177,460
Average Daily Volume (90 Day) i1,531,3621,203,818
Shares Outstanding i539.25M807.62M
Float Shares i362.33M562.88M
% Held by Insiders i0.32%0.31%
% Held by Institutions i0.44%0.41%

Dividend Analysis & Yield Comparison: Laurus Labs vs Cipla

MetricLAURUSLABSCIPLA
Last 12-Month Dividend i₹1.20₹26.00
Last 12-Month Dividend Yield i0.18%1.72%
3-Year Avg Annual Dividend i₹1.33₹16.00
3-Year Avg Dividend Yield i0.16%0.76%
3-Year Total Dividends i₹4.00₹48.00
Ex-Dividend DateMay 09, 2025Jun 27, 2025